311 related articles for article (PubMed ID: 20644497)
1. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis.
Hemmerling A; Harrison W; Schroeder A; Park J; Korn A; Shiboski S; Foster-Rosales A; Cohen CR
Sex Transm Dis; 2010 Dec; 37(12):745-50. PubMed ID: 20644497
[TBL] [Abstract][Full Text] [Related]
2. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
[TBL] [Abstract][Full Text] [Related]
3. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
[TBL] [Abstract][Full Text] [Related]
4. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis.
Antonio MA; Rabe LK; Hillier SL
J Infect Dis; 2005 Aug; 192(3):394-8. PubMed ID: 15995952
[TBL] [Abstract][Full Text] [Related]
5. Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis.
Hemmerling A; Harrison W; Schroeder A; Park J; Korn A; Shiboski S; Cohen CR
Sex Transm Dis; 2009 Sep; 36(9):564-9. PubMed ID: 19543144
[TBL] [Abstract][Full Text] [Related]
6. Comparison of main lactobacillus species between healthy women and women with bacterial vaginosis.
Yan DH; Lü Z; Su JR
Chin Med J (Engl); 2009 Nov; 122(22):2748-51. PubMed ID: 19951608
[TBL] [Abstract][Full Text] [Related]
7. Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease.
Hemmerling A; Wierzbicki MR; Armstrong E; Cohen CR
Sex Transm Dis; 2024 Jun; 51(6):437-440. PubMed ID: 38733973
[TBL] [Abstract][Full Text] [Related]
8. Vaginal retention of locally administered clindamycin.
Eriksson K; Larsson PG; Nilsson M; Forsum U
APMIS; 2011 Jun; 119(6):373-6. PubMed ID: 21569095
[TBL] [Abstract][Full Text] [Related]
9. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
Barrons R; Tassone D
Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence.
Bohbot JM; Daraï E; Bretelle F; Brami G; Daniel C; Cardot JM
J Gynecol Obstet Hum Reprod; 2018 Feb; 47(2):81-86. PubMed ID: 29196153
[TBL] [Abstract][Full Text] [Related]
11. [Lactofem--using of vital lactic acid bacteria in the cases of vaginal microflora imbalance].
Sigridov I; Ivanov S; Tiufekchieva E
Akush Ginekol (Sofiia); 2006; 45(6):55-8. PubMed ID: 17168486
[TBL] [Abstract][Full Text] [Related]
12. [Physiological recovery of vaginal flora, prophylaxis and treatment of bacterial vaginosis].
Akush Ginekol (Sofiia); 2008; 47(5):47-8. PubMed ID: 19227776
[No Abstract] [Full Text] [Related]
13. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
[TBL] [Abstract][Full Text] [Related]
14. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules.
Eriksson K; Carlsson B; Forsum U; Larsson PG
Acta Derm Venereol; 2005; 85(1):42-6. PubMed ID: 15848990
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial.
Tomusiak A; Strus M; Heczko PB; Adamski P; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M
Drug Des Devel Ther; 2015; 9():5345-54. PubMed ID: 26451088
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.
Mastromarino P; Macchia S; Meggiorini L; Trinchieri V; Mosca L; Perluigi M; Midulla C
Clin Microbiol Infect; 2009 Jan; 15(1):67-74. PubMed ID: 19046169
[TBL] [Abstract][Full Text] [Related]
17. Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli.
Antonio MA; Meyn LA; Murray PJ; Busse B; Hillier SL
J Infect Dis; 2009 May; 199(10):1506-13. PubMed ID: 19331578
[TBL] [Abstract][Full Text] [Related]
18. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
[TBL] [Abstract][Full Text] [Related]
19. Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.
Cohen CR; Wierzbicki MR; French AL; Morris S; Newmann S; Reno H; Green L; Miller S; Powell J; Parks T; Hemmerling A
N Engl J Med; 2020 May; 382(20):1906-1915. PubMed ID: 32402161
[TBL] [Abstract][Full Text] [Related]
20. Vaginal colonization by orally administered Lactobacillus rhamnosus GG.
Colodner R; Edelstein H; Chazan B; Raz R
Isr Med Assoc J; 2003 Nov; 5(11):767-9. PubMed ID: 14650098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
